City
Epaper

India reliable partner of US, working on at least 3 COVID-19 vaccines: Ambassador Sandhu

By ANI | Updated: May 10, 2020 10:45 IST

The Indian and American pharmaceutical companies are currently working together on at least three possible vaccines to fight the coronavirus, India Ambassador to the United States, Taranjit Singh Sandhu, told ANI on Saturday.

Open in App

The Indian and American pharmaceutical compes are currently working together on at least three possible vaccines to fight the coronavirus, India Ambassador to the United States, Taranjit Singh Sandhu, told on Saturday.

Sandhu said that India is a "reliable partner" to the US and has been able to fulfil whatever assistance Washington has required.

"Both International Centre for Medical Education and Research (ICMER) and here the Centers for Disease Control and Prevention as well as the National Institutes of Health (NIH), have been collaborating for a number of years. There is close cooperation exchange of information. Plus, as I said, collaboration, the at least three vaccines, on which Indian compes, and the United States compes are working together," Sandhu said.

He further noted that this is not the first time when the two countries are collaborating over the exchange of information related to medical research. In fact, he said, about two or three years back the ICMR and the CDC had together developed a vaccine for another virus, named the rotavirus. "It has helped not only India but the United States as well along with many other countries," Sandhu said.

The US and India have been closely cooperating during COVID-19 crisis and are providing all possible assistance to each other. The leaders of the two countries are in regular touch since the outbreak on the virus.

The US has provided almost USD 5.9 million towards health assistance to India to curb the spread of COVID-19.

Meanwhile, India also exported a consignment of hydroxychloroquine (HCQ) tablets to the US, last month, after a request by President Donald Trump. The HCQ is an anti-malarial drug and has only been recommended as prophylaxis of COVID-19 as per the national taskforce for COVID-19. It is not a cure but this protocol has been recommended by the national task force for mostly frontline healthcare workers and has been approved by the Drug Controller General of India (DCGI) for restricted use in an emergency situation.

Apart from domestic use, India has also exported close to three million of HCQ tablets to more than 87 countries, garnering praise from heads of state of various nations.

( With inputs from ANI )

Tags: International centre for medical education and researchDonald TrumpCenters for disease control and preventionUs centers for disease control and preventionU.s. centers for disease control and preventionDisease control and researchDisease control and preventionTaranjit singh sandhuUs centres for disease control and prevention
Open in App

Related Stories

InternationalUS Achieved All Military Objectives in Operation Epic Fury Against Iran, Says White House Press Secretary Karoline Leavitt

InternationalIran Faces 8pm Deadline From the US: White House

InternationalUS Official Confirms Strike at “Dozens of Military Targets” on Iran’s Kharg Island: Report

InternationalIran Formally Rejects US Ceasefire Proposal, Presents 10-Point Plan To Permanently End War

InternationalUS, Iran and Group of Mediators Make Push for 45-Day Ceasefire: Report

International Realted Stories

InternationalUS chose to use Pakistan as facilitator for own reasons: Israeli envoy on Iran ceasefire

InternationalIran hardens position, says no negotiations on nuclear enrichment programme

InternationalEast Turkistan movement marks 81st anniversary of National Army, renews call for independence

International"India, US have much to offer one another," US Embassy in India posts Vance's quote

International"Iran honours its words": Deputy FM Saeed Khatibzadeh signals readiness for peace talks despite "critical" escalation